Loading viewer...
earnings
Format: PDF earnings
Natera's Q3 2022 earnings presentation reports $210.6M in total revenue with 33% YoY growth and 518K tests processed. The company highlighted strong momentum in oncology testing with 53K Signatera tests (150%+ YoY growth) and expanded reimbursement coverage, while announcing updated full-year revenue guidance of $810M-$830M.
earnings
21 Pages
earnings
29 Pages
Qantas Airways Limited
PayPal Q3 2022 Investor Update - Earnings Presentation
earningsearnings
30 Pages
PayPal Holdings, Inc.
Viavi Solutions Fiscal 4Q 2023 Earnings Call Slides
earningsearnings
20 Pages
Viavi Solutions Inc.